Works matching IS 13520504 AND DT 2017 AND VI 24 AND IP 4

Results: 12

HBV/ HCV co-infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in China.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 312, doi. 10.1111/jvh.12644
By:
- Xiong, H.;
- Rong, X.;
- Wang, M.;
- Xu, R.;
- Huang, K.;
- Liao, Q.;
- Huang, J.;
- Chen, J.;
- Li, C.;
- Tang, X.;
- Shan, Z.;
- Zhang, M.;
- Nelson, K.;
- Fu, Y.
Publication type:
Article
Issue Information.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 259, doi. 10.1111/jvh.12591
Publication type:
Article
Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 268, doi. 10.1111/jvh.12639
By:
- Elbasha, E.;
- Greaves, W.;
- Roth, D.;
- Nwankwo, C.
Publication type:
Article
Cover Image.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. i, doi. 10.1111/jvh.12588
By:
- Elbasha, E.;
- Greaves, W.;
- Roth, D.;
- Nwankwo, C.
Publication type:
Article
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 280, doi. 10.1111/jvh.12641
By:
- Alqahtani, S.;
- Ozaras, R.;
- Isakov, V.;
- Wyles, D.;
- Ferenci, P.;
- Feld, J. J.;
- Calinas, F.;
- Gschwantler, M.;
- Gane, E.;
- Crawford, D.;
- Jacobson, I. M.;
- Dumas, E. O.;
- King, M.;
- Sulkowski, M.
Publication type:
Article
Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 295, doi. 10.1111/jvh.12646
By:
- McDonald, S. A.;
- Innes, H. A.;
- Aspinall, E.;
- Hayes, P. C.;
- Alavi, M.;
- Valerio, H.;
- Goldberg, D. J.;
- Hutchinson, S. J.
Publication type:
Article
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 262, doi. 10.1111/jvh.12668
By:
- El‐Akel, W.;
- El‐Sayed, M. H.;
- El Kassas, M.;
- El‐Serafy, M.;
- Khairy, M.;
- Elsaeed, K.;
- Kabil, K.;
- Hassany, M.;
- Shawky, A.;
- Yosry, A.;
- Shaker, M. K.;
- ElShazly, Y.;
- Waked, I.;
- Esmat, G.;
- Doss, W.
Publication type:
Article
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 287, doi. 10.1111/jvh.12645
By:
- Lawitz, E.;
- Poordad, F.;
- Gutierrez, J. A.;
- Kakuda, T. N.;
- Picchio, G.;
- Beets, G.;
- Vandevoorde, A.;
- Van Remoortere, P.;
- Jacquemyn, B.;
- Luo, D.;
- Ouwerkerk‐Mahadevan, S.;
- Vijgen, L.;
- Van Eygen, V.;
- Beumont, M.
Publication type:
Article
Determination of hepatitis B phenotype using biochemical and serological markers.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 320, doi. 10.1111/jvh.12643
By:
- Di Bisceglie, A. M.;
- Lombardero, M.;
- Teckman, J.;
- Roberts, L.;
- Janssen, H. L. A.;
- Belle, S. H.;
- Hoofnagle, J. H.;
- Lau, Daryl T‐Y;
- Chung, Raymond T.;
- Smith, Coleman I.;
- ‐Melman, Mauricio;
- Wong, David K.;
- Juan, Joshua;
- Feld, Jordan;
- Yim, Colina;
- Heathcote, Jenny;
- Lee, William M.;
- Perrillo, Robert;
- Do, Son;
- Han, Steven‐Huy B.
Publication type:
Article
Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 337, doi. 10.1111/jvh.12649
By:
- Chuai, X.;
- Chen, P.;
- Chen, H.;
- Wang, W.;
- Deng, Y.;
- Ruan, L.;
- Li, W.;
- Tan, W.
Publication type:
Article
The association between hepatitis B self-awareness and depression: Exploring the modifying effects of socio-economic factors.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 330, doi. 10.1111/jvh.12647
By:
- Liu, Y.;
- Tang, K.;
- Long, J.;
- Zhao, C.
Publication type:
Article
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 304, doi. 10.1111/jvh.12648
By:
- Alonso, S.;
- Riveiro‐Barciela, M.;
- Fernandez, I.;
- Rincón, D.;
- Real, Y.;
- Llerena, S.;
- Gea, F.;
- Olveira, A.;
- Fernandez‐Carrillo, C.;
- Polo, B.;
- Carrión, J. A.;
- Gómez, A.;
- Devesa, M. J.;
- Baliellas, C.;
- Castro, Á.;
- Ampuero, J.;
- Granados, R.;
- Pascasio, J. M.;
- Rubín, A.;
- Salmeron, J.
Publication type:
Article